Scholarlink

Purpose <p>The purpose of this study was to explore how haematopoietic cell transplantation (HCT) recipients define quality of life (QoL) and the impact of receiving a stem cell transplant.</p> Methods <p>Qualitative one-on-one semi-structured interviews were conducted with patients aged ≥ 18&#xa0;years who had received HCT. Interviews were audio recorded, transcribed verbatim and thematically analysed using NVivo 14 software. A patient advisory group (<i>n</i> = 6 patients) co-designed the qualitative interview study and were involved in developing the initial coding framework and themes generated.</p> Results <p>Data saturation was reached after 21 interviews (median age 45&#xa0;years, range 26–71&#xa0;years). Participants described a change in perspective about the meaning of QoL post-transplant and having to adapt to a ‘new normal’. Specifically, patients described how being immunocompromised post HCT negatively affected social, emotional and occupational QoL. Participants described facing a new, unfamiliar reality post-transplant and a feeling of being un-prepared for the long-term impact of HCT.</p> Conclusion <p>Patients require support to cope with continuously changing physical, social, emotional and occupational challenges. Supportive care interventions should be designed to address the impact of being immunocompromised.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Understanding patient quality of life following haematopoietic cell transplant

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月10日

查看全文
  • Gemma Pugh,
  • Lauren Young,
  • Christina Yiallouridou,
  • Dawn Hart,
  • Karen Dean,
  • Robert Danby

摘要

Purpose

The purpose of this study was to explore how haematopoietic cell transplantation (HCT) recipients define quality of life (QoL) and the impact of receiving a stem cell transplant.

Methods

Qualitative one-on-one semi-structured interviews were conducted with patients aged ≥ 18 years who had received HCT. Interviews were audio recorded, transcribed verbatim and thematically analysed using NVivo 14 software. A patient advisory group (n = 6 patients) co-designed the qualitative interview study and were involved in developing the initial coding framework and themes generated.

Results

Data saturation was reached after 21 interviews (median age 45 years, range 26–71 years). Participants described a change in perspective about the meaning of QoL post-transplant and having to adapt to a ‘new normal’. Specifically, patients described how being immunocompromised post HCT negatively affected social, emotional and occupational QoL. Participants described facing a new, unfamiliar reality post-transplant and a feeling of being un-prepared for the long-term impact of HCT.

Conclusion

Patients require support to cope with continuously changing physical, social, emotional and occupational challenges. Supportive care interventions should be designed to address the impact of being immunocompromised.